Clinical trial
Phase I/II Trial Evaluating Carbon Ion Radiotherapy for the Treatment of Recurrent Rectal Cancer
NCT01528683 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I/II Trial Evaluating Carbon Ion Radiotherapy for the Treatment of Recurrent Rectal Cancer
- Lead sponsor
- University Hospital Heidelberg
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2012
- Completion date
- May 31, 2018
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent rectal cancer